Cryo-Save Group N.V. – Q3 Trading Update

November 5, 2013 Group News
Tags
,

On track with implementation of “Fit for Future” turnaround plan

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 30 September 2013.

read more

EN – Trading update Q3 2012

November 6, 2012 Group News
Tags

Restructuring and cost saving programs have positive impact

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 30 September 2012.

read more

NL – Trading update Q3 2012

November 6, 2012 Group News
Tags

Positieve impact herstructurering- en kostenbesparingsprogramma’s

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 30 September 2012.

read more

Q3 2009 sample storage results

October 6, 2009 Financial Reports , Group News

New storage record – 7,300 samples stored in Q3 2009, 12% up on Q3 2008 and 4% up on Q2 2009

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has published its Q3 2009 sample storage numbers for the quarter to 30 September 2009.

7,300 samples were stored in Q3 2009, up 12% over Q3 2008 (6,500 samples), and up 4% over Q2 2009 (7,000 samples). This is again an all time record for the Group.

read more